A tumoral and invasive phenotype independent of c-Met mutation

A tumoral and invasive phenotype independent of c-Met mutation

Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal.

Bibliographic Details
Main Author:	Giannini, Giuseppe
Other Authors:	Noël, Josette
Language:	en
Published:	2016
Subjects:	HGF-R/c-Met Auto-phosphorylation Invasive Tumeur Agar mou MDCK Mutation Domaine tyrosine kinase
Online Access:	http://hdl.handle.net/1866/14926

Similar Items

Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation
by: Yumiko Tahira, et al.
Published: (2021-08-01)

MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential?
by: El Darsa H, et al.
Published: (2020-10-01)

Met-HGF/SF Signal Transduction Induces Mimp, a Novel Mitochondrial Carrier Homologue, Which Leads to Mitochondrial Depolarization
by: Gil M. Yerushalml, et al.
Published: (2002-01-01)

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
by: Nichola Cruickshanks, et al.
Published: (2017-07-01)

Rôle de la protéine d'échafaudage Gab1 dans le pouvoir oncogénique du récepteur Met dans les cellules épithéliales intestinales
by: Galoul, Mohamed Chérif
Published: (2012)

The role of HGF/c-MET signaling pathway in lymphoma
by: Bao Quoc Lam, et al.
Published: (2016-12-01)

Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
by: Victoria M Villaflor, et al.
Published: (2013-01-01)

Decreased expression of Met during differentiation in rat lung
by: T. Kato, et al.
Published: (2016-02-01)

The Pathogenetic Role of the HGF/c-Met System in Papillary Carcinoma of the Thyroid
by: Luigi Ruco, et al.
Published: (2014-10-01)

HGF/MET and the Immune System: Relevance for Cancer Immunotherapy
by: Federica Papaccio, et al.
Published: (2018-11-01)

c-Met and miRs in Cancer
by: Simona Giglio, et al.
Published: (2015-01-01)

HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation
by: Anna Spina, et al.
Published: (2015-01-01)

Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling
by: Tong Cao, et al.
Published: (2018-08-01)

Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
by: Dai Yao, et al.
Published: (2012-05-01)

Structural and Functional Insight Into the Glycosylation Impact Upon the HGF/c-Met Signaling Pathway
by: Xinyue Hu, et al.
Published: (2020-06-01)

Adipose-Derived Stem Cells Promote Proliferation and Invasion in Cervical Cancer by Targeting the HGF/c-MET Pathway
by: Zhai Y, et al.
Published: (2020-11-01)

HGF&#8211;MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics
by: Shinya Mizuno, et al.
Published: (2013-01-01)

Research Progress of HGF/c-MET Inhibitor in the Treatment  of Non-small Cell Lung Cancer
by: Tao JIANG, et al.
Published: (2015-04-01)

HGF/MET Signaling in Malignant Brain Tumors
by: Elizabeth Qian Xu Mulcahy, et al.
Published: (2020-10-01)

MET Exon 14 Skipping Mutations in Non-small Cell Lung Cancer
by: Limei YIN, et al.
Published: (2018-07-01)

Stepwise participation of HGF/MET signaling in the development of migratory muscle precursors during vertebrate evolution
by: Noritaka Adachi, et al.
Published: (2018-06-01)

A receptor-antibody hybrid hampering MET-driven metastatic spread
by: Chiara Modica, et al.
Published: (2021-01-01)

MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside
by: Max Hardy-Werbin, et al.
Published: (2019-09-01)

Cyclic Peptide-Based Biologics Regulating HGF-MET
by: Hiroki Sato, et al.
Published: (2020-10-01)

Dysregulation of HGF/c-Met Signal Pathway and Their Targeting Drugs in Lung Cancer
by: Yongwen LI, et al.
Published: (2014-08-01)

c-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences
by: Giuditta Viticchiè, et al.
Published: (2015-01-01)

HGF/c-MET Signaling in Melanocytes and Melanoma
by: Malgorzata Czyz
Published: (2018-12-01)

Mechanism of c-MET in Non-small Cell Lung Cancer and Its Treatment and Testing
by: Hongge LIANG, et al.
Published: (2015-12-01)

Targeting HGF/c-MET Axis in Pancreatic Cancer
by: Srinivasa P. Pothula, et al.
Published: (2020-12-01)

The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy
by: Helen F. Titmarsh, et al.
Published: (2020-02-01)

Research Progress of HGF/MET Signaling Pathway in EGFR-TKI Resistance  in Non-small Cell Lung Cancer
by: Shilong SONG, et al.
Published: (2014-10-01)

MET in glioma: signaling pathways and targeted therapies
by: Fangling Cheng, et al.
Published: (2019-06-01)

Corrigendum: The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy
by: Helen F. Titmarsh, et al.
Published: (2020-08-01)

Dysregulated HAI-2 Plays an Important Role in Renal Cell Carcinoma Bone Metastasis through Ligand-Dependent MET Phosphorylation
by: Koji Yamasaki, et al.
Published: (2018-06-01)

PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
by: Lluís Nisa, et al.
Published: (2017-05-01)

Le rôle de la PI3-kinase dans le phénotype invasif et motile des cellules MSV-MDCK-INV
by: Dodier, Yolaine
Published: (2016)

HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers
by: Hongli Zhang, et al.
Published: (2018-10-01)

Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment
by: Yilong Zhang, et al.
Published: (2015-03-01)

Transgéline dans la carcinogénèse colorectale induite par Met
by: Champagne, Audrey
Published: (2015)

c-Met Signaling Pathway Participating in the Gefitinib Resistance of Different Gene Types of Non-small Cell Lung Cancer Cells Induced by HGF In Vitro
by: Xianglan XUAN, et al.
Published: (2013-09-01)